Elsevier

European Urology

Volume 66, Issue 5, November 2014, Pages 811-814
European Urology

Brief Correspondence
Predictors of Cancer-specific Mortality After Disease Recurrence in Patients with Squamous Cell Carcinoma of the Penis

https://doi.org/10.1016/j.eururo.2014.05.032Get rights and content

Abstract

Disease recurrence occurs frequently after surgical treatment for squamous cell carcinoma of the penis (SCCp). We sought to determine prognostic factors that influence cancer-specific mortality (CSM) after disease recurrence in patients with SCCp. We performed a retrospective analysis of 314 patients who experienced disease recurrence after surgical treatment for SCCp between 1949 and 2012. Competing risk regression analysis addressed factors associated with CSM after SCCp recurrence. Median time from surgery to disease recurrence was 10.5 mo (interquartile range [IQR]: 5.9–21.3). Of the recurrences, 165 (53%), 118 (38%), and 31 (9.9%) were local, regional, or distant, respectively. Within a median follow-up of 4.5 yr (IQR: 2.0–6.5), 108 patients died of SCCp and 41 patients died of causes other than SCCp. Shorter time to disease recurrence was found to be significantly associated with a higher risk of CSM (p = 0.0006). Lymph node metastasis at the time of initial treatment (subdistribution hazard ratio [SHR]: 1.96; 95% confidence interval [CI] 1.23– 3.11; p = 0.005) and regional recurrence (SHR: 4.14; 95% CI, 2.16–7.93; p < 0.0001) or distant recurrence (SHR: 5.75; 95% CI, 2.59–12.73; p < 0.0001) were associated with increased risk of CSM after disease recurrence. Inclusion of time to recurrence into risk stratification may help patient counseling and treatment planning.

Cited by (11)

  • Management of Advanced Penile Cancer

    2021, Mayo Clinic Proceedings
    Citation Excerpt :

    A review of the currently available systemic chemotherapy regimens is summarized in Table 1.40,41–43,44 Unfortunately, there are currently no clinical or pathologic factors that can accurately predict a patient’s benefit from neoadjuvant chemotherapy.49–51 The only strong predictor of better survival after neoadjuvant chemotherapy is achievement of a pCR at the time of consolidative surgical treatment.41

  • Survival outcomes of organ sparing surgery, partial penectomy, and total penectomy in pathological T1/T2 penile cancer: Report from the National Cancer Data Base

    2018, Urologic Oncology: Seminars and Original Investigations
    Citation Excerpt :

    TP has a low recurrence rate in early stage PC. However the psychological and functional outcomes of the procedure are devastating [8]. PP is associated with a low recurrence rate in early stage PC [9,10].

  • Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis

    2017, Human Pathology
    Citation Excerpt :

    Intriguingly, although FISH alterations represented an independent risk factor for death from cancer, they were not associated with recognized clinical and pathological variables of unfavorable outcome, with the exception of histologic grade, as only 1 low-grade tumor presented FISH alterations. High histologic grade has been described extensively as a variable forecasting a poor prognosis in PC [1,2,11,12], as have lymph node involvement and perineural invasion [3,4,11,37]. Nearly half (14 of 31) of the cases without FISH alterations were clinically N1 or N2; 7 of them also had pathologically confirmed lymph node involvement, but the patients did not die of the disease.

  • Epithelial-mesenchymal transition (EMT) phenotype at invasion front of squamous cell carcinoma of the penis influences oncological outcomes

    2016, Urologic Oncology: Seminars and Original Investigations
    Citation Excerpt :

    Clinical stage, histological subtype and grade, pattern of invasion, perineural/vascular invasion, and lymph node metastasis are the most important prognostic factors in PC. But, these parameters are difficult to apply to small biopsies, because PC is heterogeneous, especially when it invades preputial lamina propria or corpus spongiosum/cavernosum [2,3,7,11]. The identification of new molecular prognostic markers can assist in managing this group of patients and possibly avoid aggressive treatments, such as extended lymphadenectomy (Table 4).

View all citing articles on Scopus

Both authors contributed equally to this manuscript.

View full text